1. Rubboli, A., C. Becattini, and F.W. Verheugt, Incidence, clinical impact and risk of bleeding during oral anticoagulation therapy. World J Cardiol, 2011. 3(11): p. 351-8. https://www.ncbi.nlm.nih.gov/pubmed/22125670
2. Little, D., et al., Resumption of anticoagulant therapy after anticoagulant-related gastrointestinal bleeding: A systematic review and meta-analysis. Thrombosis research, 2019. 175: p. 102-109. https://www.thrombosisresearch.com/article/S0049-3848(19)30029-5/fulltext
3. Witt, D.M., What to do after the bleed: resuming anticoagulation after major bleeding. Hematology. American Society of Hematology. Education Program, 2016. 2016(1): p. 620-624. https://www.ncbi.nlm.nih.gov/pubmed/27913537
4. Qureshi, W., et al., Restarting anticoagulation and outcomes after major gastrointestinal bleeding in atrial fibrillation. Am J Cardiol, 2014. 113(4): p. 662-8. https://www.ncbi.nlm.nih.gov/pubmed/24355310
5. Witt, D.M., et al., Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding. Arch Intern Med, 2012. 172(19): p. 1484-91. https://www.ncbi.nlm.nih.gov/pubmed/22987143
6. Staerk, L., et al., Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study. BMJ, 2015. 351: p. h5876. https://www.bmj.com/content/bmj/351/bmj.h5876.full.pdf
7. Sengupta, N., et al., The risks of thromboembolism vs. recurrent gastrointestinal bleeding after interruption of systemic anticoagulation in hospitalized inpatients with gastrointestinal bleeding: a prospective study. Am J Gastroenterol, 2015. 110(2): p. 328-35. https://www.ncbi.nlm.nih.gov/pubmed/25512338
8. Little DHW, Sutradhar R, Cerasuolo JO, et al. Rates of rebleeding, thrombosis and mortality associated with resumption of anticoagulant therapy after anticoagulant-related bleeding. CMAJ. 2021;193(9):E304
9. Heuschmann, P.U., et al., Three-month stroke outcome: the European Registers of Stroke (EROS) investigators. Neurology, 2011. 76(2): p. 159-65. https://www.ncbi.nlm.nih.gov/pubmed/21148118
10. Koton, S., et al., Stroke incidence and mortality trends in US communities, 1987 to 2011. Jama, 2014. 312(3): p. 259-68. https://www.ncbi.nlm.nih.gov/pubmed/25027141
11. Sengupta, N., et al., Rebleeding vs Thromboembolism After Hospitalization for Gastrointestinal Bleeding in Patients on Direct Oral Anticoagulants. Clin Gastroenterol Hepatol, 2018. 16(12): p. 1893-1900.e2. https://www.ncbi.nlm.nih.gov/pubmed/29775794
12. Majeed, A., et al., Optimal timing of vitamin K antagonist resumption after upper gastrointestinal bleeding. A risk modelling analysis. Thromb Haemost, 2017. 117(3): p. 491-499. https://www.ncbi.nlm.nih.gov/pubmed/28004062